| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.01B | 7.05B | 6.13B | 5.32B | 4.62B | 4.20B |
| Gross Profit | 6.02B | 5.43B | 4.88B | 4.29B | 3.72B | 3.34B |
| EBITDA | 2.64B | 2.50B | 1.85B | 1.56B | 1.33B | 1.01B |
| Net Income | 1.10B | 1.33B | 2.26B | 1.23B | 984.59M | 757.52M |
Balance Sheet | ||||||
| Total Assets | 47.24B | 48.22B | 13.07B | 10.33B | 9.42B | 8.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.20B | 2.96B | 4.05B | 1.59B | 1.57B | 1.58B |
| Total Debt | 10.04B | 14.29B | 684.46M | 677.60M | 656.37M | 666.77M |
| Total Liabilities | 16.69B | 19.90B | 4.05B | 4.15B | 3.86B | 3.45B |
| Stockholders Equity | 30.55B | 28.33B | 8.99B | 6.15B | 5.52B | 5.30B |
Cash Flow | ||||||
| Free Cash Flow | 2.28B | 1.35B | 1.28B | 1.51B | 1.60B | 1.40B |
| Operating Cash Flow | 2.44B | 1.52B | 1.41B | 1.70B | 1.74B | 1.49B |
| Investing Cash Flow | -15.90B | -15.91B | 1.22B | -482.10M | -572.62M | -549.03M |
| Financing Cash Flow | 11.80B | 13.39B | -181.30M | -1.20B | -1.12B | -748.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $115.65B | 19.13 | 55.43% | ― | 10.53% | 34.24% | |
72 Outperform | $62.46B | 31.84 | 135.72% | ― | 14.78% | 22.52% | |
72 Outperform | $133.14B | 71.18 | 16.26% | ― | 15.30% | -60.71% | |
66 Neutral | $26.04B | -232.70 | -3.56% | ― | 23.24% | -8.83% | |
66 Neutral | $84.73B | 287.80 | 5.55% | ― | 12.62% | -45.12% | |
65 Neutral | $444.88B | 23.45 | 70.60% | 1.00% | 11.08% | 29.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On March 2, 2026, Synopsys announced it had entered into a $250 million accelerated share repurchase agreement with The Bank of Nova Scotia to buy back its common stock. The move underlines the company’s capital return strategy and could signal confidence in its valuation, with implications for earnings per share and shareholder returns.
Under the agreement, Synopsys is set to receive an initial delivery of about 513,000 shares, with the final number of shares to be determined based on the volume-weighted average price of its stock during the repurchase period, less a discount. Settlement of any remaining shares is expected on or before June 1, 2026, tying the ultimate size of the buyback to market conditions over the coming months.
The most recent analyst rating on (SNPS) stock is a Hold with a $480.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.
On Feb. 25, 2026, Synopsys reported first-quarter fiscal 2026 revenue of $2.409 billion, up from $1.455 billion a year earlier, with GAAP EPS of $0.34 and non-GAAP EPS of $3.77, both at or above guidance. Management highlighted strong execution, an AI-driven uplift in system-level and semiconductor R&D demand, and reiterated full-year revenue expectations around $9.61 billion, including a sizable Ansys contribution.
The board also replenished Synopsys’ stock repurchase program, authorizing buybacks of up to $2 billion of common stock, a move that underscores confidence in the company’s growth trajectory and capital-return strategy. Synopsys issued financial targets for the second quarter and full fiscal 2026, signaling continued investment discipline as it seeks to capitalize on an expanded market opportunity and reinforce its competitive position in chip design and systems engineering tools.
The most recent analyst rating on (SNPS) stock is a Hold with a $455.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.
On February 14, 2026, Synopsys’ board expanded from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as an independent director and audit committee member, effective immediately. Shimer, an audit committee financial expert with four decades at Deloitte and current roles at Alaska Air Group and cancer-focused AI initiatives, will receive standard non-employee director compensation, reinforcing Synopsys’ financial oversight as it scales its AI-driven silicon-to-systems platform.
In a related February 19, 2026 announcement, Synopsys said it would not renominate directors Luis Borgen and Dr. Ajei Gopal for re-election, though both will serve until the 2026 annual meeting. The board framed these moves, which come as the Ansys integration progresses, as part of a broader commitment to director refreshment and governance evolution to support the company’s leadership in the growing silicon-to-systems engineering market.
The most recent analyst rating on (SNPS) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.